Manipulating microglia

How Alector plans to deploy its $133M series E round

Alector Inc.’s $133 million series E round provides enough runway for the immuno-neurology and immuno-oncology company to take at least five programs into the clinic in the next two years.

Participants in the untranched round,

Read the full 358 word article

User Sign In